Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

Would Active Surveillance Cultures Help Control Healthcare‐Related Methicillin‐Resistant Staphylococcus aureus Infections?

Barry M. Farr , MD, MSc and William R. Jarvis , MD
Infection Control and Hospital Epidemiology
Vol. 23, No. 2 (February 2002), pp. 65-68
DOI: 10.1086/502008
Stable URL: http://www.jstor.org/stable/10.1086/502008
Page Count: 4
  • Subscribe ($19.50)
  • Cite this Item
Would Active Surveillance Cultures Help Control Healthcare‐Related Methicillin‐Resistant Staphylococcus aureus Infections?
Preview not available

Abstract

EXCERPT In 1934, Reinhold Niebuhr penned lines that could almost serve as a mantra for healthcare epidemiology: “God give us grace to accept with serenity the things that cannot be changed, courage to change the things which should be changed and wisdom to distinguish the one from the other.” In the same year, however, T. S. Eliot wrote lines that also resonate strongly and appear to many to sometimes represent a better description of what is actually happening: “Where is the wisdom we have lost in knowledge? Where is the knowledge we have lost in information?” Conflicts about what can and should be changed and the knowledge and wisdom to recognize these situations seem to be what healthcare epidemiology is all about. In this issue, the Rhode Island Best Practice Guideline for controlling methicillin‐resistant Staphylococcus aureus (MRSA)1 addresses the control of one of the major causes of antibiotic‐resistant healthcare‐associated infections in U.S. hospitals. National secular trend data since the early 1980s have shown that the prevalence of MRSA keeps increasing every year. The Centers for Disease Control and Prevention (CDC) has estimated that approximately 13,300 Americans died in 1992 of healthcare‐associated infections caused by antibiotic‐resistant pathogens. The rates of such infections (and of deaths directly or indirectly caused by these infections) have continued to rise each year. This means that, during the past decade, approximately 130,000 to 150,000 patients have died of these infections in U.S. hospitals. It should be remembered that control of healthcare‐associated antibiotic‐resistant pathogens was the reason that infection control programs were created in the first place, back in the early 1970s. This had followed two decades of steady increases in penicillin resistance and the development of a consensus that finding an effective means of prevention might be preferable to seeking another cure (because infections caused by antibiotic‐resistant pathogens seemed to be more deadly than those due to antibiotic‐susceptible strains of the same species and because an apparent panacea like penicillin really hadn’t worked for all that long). Research during the past 50 years has confirmed repeatedly that antibiotic use and patient‐to‐patient spread are the two most important risk factors for infections caused by antibiotic‐resistant pathogens.

Page Thumbnails